Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Laboratory findings in optic-spinal multiple sclerosis].

Kazuo Fujihara1

  • 1Department of Neurology, Tohoku University School of Medicine.

Rinsho Shinkeigaku = Clinical Neurology
|April 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neuromyelitis optica spectrum disorders.

Therapeutic advances in neurological disorders·2026
Same author

Outcomes and disease activity during and after pregnancy in Asian women with MOGAD.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Current evidence and knowledge gaps in family planning and pregnancy in myasthenia gravis, NMOSD, and MOGAD.

The Lancet. Neurology·2026
Same author

Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Characteristic patterns of complement deposition in NMOSD, MOGAD, and MS.

Acta neuropathologica·2026

Optic-spinal multiple sclerosis (OSMS) is distinct from classical MS, with neuromyelitis optica (NMO) showing unique CSF findings and neuropathology. NMO-IgG positivity is linked to severe optic-spinal disease and distinct brain lesions.

Area of Science:

  • Neurology
  • Immunology
  • Neuroimmunology

Context:

  • Optic-spinal multiple sclerosis (OSMS) presents with severe optic nerve and spinal cord involvement.
  • Neuromyelitis optica (NMO) is a related condition with distinct pathological and laboratory features.
  • Understanding these differences is crucial for diagnosing and treating OSMS subtypes.

Purpose:

  • To differentiate neuromyelitis optica (NMO) from classical multiple sclerosis (MS) based on clinical and laboratory findings.
  • To highlight the unique neuropathological characteristics of NMO.
  • To introduce NMO-IgG as a disease-specific marker and discuss its clinical implications.

Summary:

  • OSMS can be classified into NMO and MS with optic-spinal presentation.
  • NMO exhibits negative oligoclonal IgG bands and normal IgG1% in CSF, unlike classical MS.

Related Experiment Videos

  • Elevated CSF neurofilament heavy chain in NMO suggests greater axonal damage, with unique findings like tissue necrosis and perivascular immunoglobulin deposition.
  • NMO-IgG positivity correlates with severe visual loss, extensive myelitis, and distinct brain lesions.

    • Impact:

    • Clarifies the distinction between NMO and classical MS, aiding accurate diagnosis.
    • Identifies NMO-IgG as a key biomarker for severe optic-spinal disease.
    • Provides insights into the unique pathogenesis and neuropathology of NMO, guiding future research and therapeutic strategies.